Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Johnson and Johnson
Dow
QuintilesIMS
Accenture
Julphar
Queensland Health
Colorcon
Mallinckrodt

Generated: May 25, 2018

DrugPatentWatch Database Preview

Hydralazine hydrochloride; reserpine - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for hydralazine hydrochloride; reserpine and what is the scope of hydralazine hydrochloride; reserpine freedom to operate?

Hydralazine hydrochloride; reserpine
is the generic ingredient in two branded drugs marketed by Sandoz and Novartis, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for hydralazine hydrochloride; reserpine.
Summary for hydralazine hydrochloride; reserpine
US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: 20
Clinical Trials: 54
DailyMed Link:hydralazine hydrochloride; reserpine at DailyMed

US Patents and Regulatory Information for hydralazine hydrochloride; reserpine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis SERPASIL-APRESOLINE hydralazine hydrochloride; reserpine TABLET;ORAL 009296-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz DRALSERP hydralazine hydrochloride; reserpine TABLET;ORAL 084617-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis SERPASIL-APRESOLINE hydralazine hydrochloride; reserpine TABLET;ORAL 009296-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
UBS
Boehringer Ingelheim
McKinsey
QuintilesIMS
US Department of Justice
Accenture
Chubb
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.